Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
about
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SManaging chronic hepatitis C in the difficult-to-treat patientUnhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis CHepatitis C treatment experiences and decision making among patients living with HIV infection.Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studiesThe practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation.The implications of substance misuse for intravenous conscious sedation practice.Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting.Hepatitis C and leptospirosis: simultaneous acute infections or recurrence of occult hepatitis C.Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond.Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users.
P2860
Q27489610-4166525A-F2E2-4013-9CF4-5BCDE6B8D6EAQ27490409-486003BE-2995-4E6F-9D4E-0D27DD56E99FQ28484313-27D7F96B-FD02-43D1-A638-35EAA680E73CQ33636377-731A8434-F544-4770-AED7-8F0FA021748CQ33872878-231487B5-7A03-4CBD-8E3D-A5D3900E0967Q34996746-F1CAA5A5-A07B-444C-86E4-A921D082D700Q35235877-AB3BB485-9F50-442E-8716-95D3863310C7Q35737654-46D108D1-1C69-4CE6-AC47-1CAFFB2E70DEQ36418455-AFA07186-505A-45BE-B2C2-B95309A05134Q37637357-BFB7AF3F-EE2F-48D3-8E4D-38125F592F0BQ38365601-97C9502F-5227-477E-8B7B-EB4075AE37C3Q40123381-FAEC7CF5-4A1A-40C1-A19E-DBE0C535E70EQ41127775-4362A172-32B4-47E5-9E58-E400BD63F63CQ43041036-6E1C04F2-D7E0-4594-92B7-C35421AB9215Q44332479-A334D362-0E77-45DB-84AD-FB39EB67A7C8Q53516509-E3163BA8-20AD-49EE-BE41-4F3031859F83
P2860
Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Epidemiology and natural histo ...... s: implications for treatment.
@ast
Epidemiology and natural histo ...... s: implications for treatment.
@en
type
label
Epidemiology and natural histo ...... s: implications for treatment.
@ast
Epidemiology and natural histo ...... s: implications for treatment.
@en
prefLabel
Epidemiology and natural histo ...... s: implications for treatment.
@ast
Epidemiology and natural histo ...... s: implications for treatment.
@en
P356
P1476
Epidemiology and natural histo ...... s: implications for treatment.
@en
P2093
David L Thomas
Mark S Sulkowski
P304
P356
10.1086/427440
P407
P478
40 Suppl 5
P577
2005-04-01T00:00:00Z